Meet with MethodSense at RSNA 2025
Imaging innovation demands regulatory clarity. MethodSense and LuminLogic provide FDA-tested compliance, AI model lifecycle controls, and evidence frameworks that accelerate commercialization and clinical adoption.
| Email Us | Call Us | Contact Form |
|---|---|---|
| Send us your compliance questions | Speak directly with our regulatory team | Schedule a meeting |
| Send an Email | +1 (919) 313-3960 | Fill Out the Form |
The Challenge: When Innovation Outpaces Regulation
Radiology innovation is advancing faster than regulatory guidance. AI/ML imaging tools, adaptive algorithms, and connected diagnostic systems demand rigorous validation, cybersecurity integrity, and post-market performance monitoring. Without a structured compliance foundation, innovators face delays, audit risk, and lost investor confidence. Scalable systems and expert regulatory guidance are critical to commercial and clinical success.
AI imaging solutions and radiology technology are evolving rapidly, and regulatory expectations are rising just as fast. Companies must:
- Design trustworthy AI validation studies
- Document algorithm change-control and performance stability
- Align with FDA SaMD & AI/ML guidance and eSTAR requirements
- Build scalable post-market performance systems
- Meet cybersecurity and transparency standards
- Preserve investor trust and clinical adoption
Our Solutions: A Structured Path to FDA Success
MethodSense combines deep regulatory expertise with the LuminLogic platform to deliver FDA-ready AI validation strategies, eSTAR submission support, cybersecurity documentation, and lifecycle control for evolving imaging models. We operationalize compliance workflows, automate evidence tracking, and provide structured post-market vigilance, enabling faster approvals, trusted clinical adoption, and reliable long-term product performance.
MethodSense provides FDA-tested regulatory consulting and the LuminLogic compliance platform to support imaging and AI developers:
- AI clinical validation strategy & evidence framework
- FDA eSTAR + SaMD submission support
- Data integrity, cybersecurity, and model release documentation
- Algorithm lifecycle & change-control frameworks
- Post-market performance monitoring & complaints/CAPA
- EU MDR + global regulatory alignment
- Investor-ready reporting & transparency tools
Why MethodSense: Regulatory Leadership You Can Trust
With 25+ years of regulatory leadership and 200+ FDA wins, MethodSense understands the complexity of medical imaging innovation. Our team specializes in AI/ML, SaMD, evidence development, and FDA eSTAR execution. Paired with LuminLogic’s structured quality and vigilance infrastructure, we accelerate innovation, strengthen investor trust, and ensure scalable compliance aligned with clinical workflows.
- 25+ years in med-device regulatory leadership
- 200+ FDA wins, including breakthrough-stage technologies
- Deep AI/ML + SaMD expertise specific to imaging
- Clinically aligned validation strategy
- Integrated consulting + compliance platform (LuminLogic)
- Proven systems that preserve capital and accelerate approvals
Built for Every Stage of Radiology Growth
AI imaging startups, imaging OEMs, radiology workflow platforms, and academic medical centers advancing clinical innovation gain clarity and confidence with MethodSense. Investors and acquisition teams benefit from transparent compliance systems and risk control. Whether developing breakthrough imaging AI or scaling device portfolios, teams receive expert guidance and proven infrastructure to meet regulatory expectations.
Benefits:
- AI imaging startups: Faster approval, structured model evolution, investor confidence
- Imaging OEMs: Scalable global compliance, smooth M&A integration, audit-ready operations
- Radiology enterprise platforms: Cybersecurity rigor, post-market vigilance, performance transparency
- AMCs & hospital innovators: Pathway from prototype to commercial-ready clinical solution
- Investors & corporate innovation teams: De-risked innovation pipeline, clear diligence visibility
Let’s Get Started: Connect with Our Regulatory Experts at RSNA
Compliance drives clinical confidence and commercial traction. Whether you’re preparing a submission, scaling post-market systems, or building evidence for imaging AI, MethodSense gives you the strategy, support, and platform to move forward quickly and safely. Connect with our team to assess your readiness and accelerate your journey from innovation to real-world impact.
Whether you’re launching AI imaging technology, scaling your portfolio, or commercializing academic innovation, MethodSense gives you the strategy, structure, and platform to move confidently.
| Email Us | Call Us | Contact Form |
|---|---|---|
| Request a Regulatory Strategy Session | Speak directly with our regulatory team | Schedule a meeting |
| Send an Email | +1 (919) 313-3960 | Fill Out the Form |
What MedTech Companies Say About MethodSense
LuminLogic has been critical in helping us prepare for ISO 13485 certification and expanding into international markets. Its validated system ensures that we can efficiently manage and organize our manufacturing processes, quality documentation, and ensure regulatory compliance. Having LuminLogic in place gives us the confidence to face audits and navigate complex regulatory environments while scaling our business.
Using LuminLogic, we were able to streamline our document management and share technical files securely with MethodSense. LuminLogic’s efficient system allowed us to transfer vital information quickly, ensuring our submissions were well-organized and compliant. This software helped us stay on track with the FDA requirements, leading to a faster approval process.
We’ve been working with MethodSense since 2016, and their guidance has been pivotal to our growth as a medical device manufacturer. I would unequivocally recommend MethodSense and LuminLogic to any medical device company looking to streamline their quality and regulatory processes and achieve operational excellence.